The Form 4 filing, a report of insider share activity, was filed with the SEC on October 13, 2026. It covers an October 12 trade by Inglis Tiffany Eul Davis, chief medical officer of Sera Prognostics (SERA).
The transaction details also point to a tax-related purpose. The footnote text was not provided, which limits what can be said about that part of the sale.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 8,024 |
| Price | $2.03 |
| Total Transaction Value | $16,288.72 |
| Insider | |
| Ticker Symbol | SERA |
| Company | SERA PROGNOSTICS, INC. |
| Insider Name | Inglis Tiffany Eul Davis |
| Insider Title | Chief Medical Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 83,565 |
| Position Size Change | 8.76% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported with transaction code S. It involved 8,024 shares in one transaction. The tax-related context does not change the reported transaction type.
What was the average price of the transaction?
The reported average price was $2.03 per share. That was the average for the shares sold on October 12, 2026.
How did this transaction affect the insider's holdings?
After selling 8,024 shares, Inglis Tiffany Eul Davis reported owning 83,565 shares. The sale represented 8.76% of the shares owned before the trade.
What's the total transaction value?
The total value was $16,288.72. That amount covers the one reported sale of 8,024 shares.
Are there any special circumstances around this transaction?
Yes. The transaction details indicate a link to covering taxes on pay in company shares. They do not confirm that taxes were the only purpose. The footnote text was not provided, so the exact terms and how any tax payment worked remain unknown.
For research purposes only; not investment advice.